Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.52 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.50 |
| ▸ | KIF11 | P52732 | 2/20 | 0.47 |
| ▸ | LPL | P06858 | 1/20 | 0.46 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.46 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.46 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.46 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.46 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.43 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.42 |
| ▸ | ERN1 | O75460 | 1/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methane SCHEMBL27303630 | 0.98 | LTA4H (0.50) | LTA4HKCNH2KIF11LPLLIPG | |
| SCHEMBL27961808 | 0.91 | PRMT6 (0.47) | LTA4HKCNH2KIF11LPLLIPG | |
| SCHEMBL21391895 | 0.89 | LTA4H (0.43) | LTA4HKCNH2KIF11LPLLIPG | |
| SCHEMBL10472472 | 0.87 | DPP4 (0.49) | LTA4HKCNH2KIF11LPLLIPG | |
| SCHEMBL16546585 | 0.84 | LTA4H (0.48) | LTA4HKCNH2LPLLIPGPRMT6 | |
| SCHEMBL9257921 | 0.84 | KIF11 (0.55) | LTA4HKCNH2KIF11LPLLIPG | |
| SCHEMBL21931869 | 0.84 | TSHR (0.44) | LTA4HKCNH2KIF11LPLLIPG | |
| SCHEMBL27961856 | 0.83 | LTA4H (0.42) | LTA4HKCNH2KIF11HDAC1HDAC2 | |
| SCHEMBL338810 | 0.82 | LTA4H (0.70) | LTA4HKCNH2LPLLIPGPRMT6 | |
| SCHEMBL20595524 | 0.82 | KCNH2 (0.48) | LTA4HKCNH2KIF11PRMT6HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113122241-A | Quantum dot material and preparation method thereof, quantum dot light-emitting diode and light-emitting device | TCL集团股份有限公司 | 2021-07-16 | — | — | CN | claimed |
| US-20230271969-A1 | NITROGEN-CONTAINING FUSED RING DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF | JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) | 2023-08-31 | — | — | US | disclosed |
| US-20230271969-A1 | NITROGEN-CONTAINING FUSED RING DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF | JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) | 2023-08-31 | — | — | US | disclosed |
| CN-108690045-B | Diarylethene compounds and uses thereof | 首诺加拿大公司 | 2022-08-30 | — | — | CN | disclosed |
| CN-111450123-B | Use of hathwayi or taurine for preparing medicine for preventing and treating intracranial aneurysm formation and rupture | 中国医学科学院阜外医院 | 2021-11-02 | — | — | CN | disclosed |
| US-10763449-B2 | Organic light-emitting diode (OLED) display panel, fabrication method and electronic device thereof | Shanghai Tianma AM-OLED Co., Ltd. (CN) | 2020-09-01 | — | — | US | disclosed |
| CN-111373077-A | Sn or Sn alloy plating solution and method for producing Sn or Sn alloy plating | 上村工业株式会社 | 2020-07-03 | — | — | CN | disclosed |
| EP-3613504-A1 | PI-ALLYLPALLADIUM AND PI-ALLYLNICKEL COMPLEXES FOR USE AS CATALYSTS IN CARBON-CARBON AND CARBON-NITROGEN COUPLING REACTIONS | Johnson Matthey Public Limited Company (GB) | 2020-02-26 | — | — | EP | disclosed |
| EP-2585216-B1 | PI-ALLYLPALLADIUM AND PI-ALLYLNICKEL COMPLEXES FOR USE AS CATALYSTS IN CARBON-CARBON AND CARBON-NITROGEN COUPLING REACTIONS | JOHNSON MATTHEY PLC (GB) | 2019-11-20 | — | — | EP | disclosed |
| US-10202354-B2 | Therapeutic compounds and uses thereof | GENENTECH, INC. (US) | 2019-02-12 | — | — | US | disclosed |
| EP-0155345-A2 | Pleochroic anthraquinone dyes | The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and (GB) | 1985-09-25 | — | — | EP | disclosed |
| EP-0142617-A1 | Pleochroic anthraquinone dyes | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1985-05-29 | — | — | EP | disclosed |
| US-4496221-A | FREE FROM WATER SOLUBILIZERS AND IONIC SUBSTIVENTS;CONTRAST | Secretary of State for Defence in Her Britanic Majesty's Government of the United Kingdom of Great Britain and Northern Ireland of Whitehall (GB) | 1985-01-29 | — | — | US | disclosed |
| US-4464282-A | ANTHRAQUINONE PLEOCHROIC DYE FOR LIQUID CRYSTALS | THE SECRETARY OF STATE FOR DEFENCE IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITIAN AND NORTHERN IRELAND (GB) | 1984-08-07 | — | — | US | disclosed |
| US-4455253-A | FOR LIQUID CRYSTAL DISPLAYS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-06-19 | — | — | US | disclosed |
| EP-0108472-A2 | Organic materials for a liquid crystal device | The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and (GB) | 1984-05-16 | — | — | EP | disclosed |
| US-4446047-A | Pleochroic anthraquinone dyes | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-05-01 | — | — | US | disclosed |
| EP-0103952-A2 | Pleochroic anthraquinone dyes | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-03-28 | — | — | EP | disclosed |
| EP-0059036-A1 | Pleochroic anthraquinone dyes | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1982-09-01 | — | — | EP | disclosed |
| EP-0059095-A1 | Liquid crystal materials comprising pleochroic dyes | The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and (GB) | 1982-09-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230271969-A1 | NITROGEN-CONTAINING FUSED RING DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF | NR5A1, WEE1, SHBG | LTA4H 1289/4885KCNH2 797/4885KIF11 628/4885 |
| US-10202354-B2 | Therapeutic compounds and uses thereof | KDM1B, KDM6B, KDM2B | LTA4H 2865/4885KCNH2 2469/4885KIF11 2129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.